Qube Research & Technologies (QRT)’s Silence Therapeutics SLN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SLN Stock Details SLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.8M	Buy	163,945 +59,390	+57%	+$418K	﹤0.01%	2169
2026 Q1	$551K	Buy	104,555 +69,593	+199%	+$383K	﹤0.01%	2707
2025 Q4	$213K	Buy	+34,962	New	+$224K	﹤0.01%	3044
2025 Q2	–	Sell	-18,913	Closed	-$53.3K	–	3932
2025 Q1	$53.3K	Sell	18,913 -35,833	-65%	-$175K	﹤0.01%	3112
2024 Q4	$377K	Buy	54,746 +35,550	+185%	+$459K	﹤0.01%	2611
2024 Q3	$349K	Buy	+19,196	New	+$357K	﹤0.01%	2384
2024 Q2	–	Sell	-3,942	Closed	-$85.1K	–	4635
2024 Q1	$85.1K	Buy	3,942 +3,764	+2,115%	+$81.8K	﹤0.01%	3361
2023 Q4	$3.09K	Hold	178	–	–	﹤0.01%	3778
2023 Q3	$1.75K	Buy	+178	New	+$1.31K	﹤0.01%	3590

Other funds holding SLN

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SLN Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Silence Therapeutics (SLN) stake by 57% in Q2 2026, buying an estimated $418K and bringing the position to 163,945 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2169.

Qube Research & Technologies (QRT) first reported a position in SLN in Q3 2023 and has held it in 9 quarters since. 72 funds tracked by Wall St. Rank hold SLN as of Q2 2026.

Qube Research & Technologies (QRT) held 163,945 shares of Silence Therapeutics worth $1.8M as of Q2 2026.
Qube Research & Technologies (QRT) bought 59,390 Silence Therapeutics shares in Q2 2026, an estimated $418K.
Silence Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2169 holding.
Qube Research & Technologies (QRT) first reported a position in Silence Therapeutics in Q3 2023 and has held it in 9 quarters since.
72 funds tracked by Wall St. Rank held Silence Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.